Thymalin 10 mg

Thymalin for Sale: Khavinson’s Thymic Polypeptide Bioregulator with 40+ Years of Clinical Research

Thymalin is unique among research peptides because of its provenance. It was developed in 1981 by Vladimir Khavinson and Vyacheslav Morozov at the St. Petersburg Institute of Bioregulation and Gerontology, and registered as a pharmaceutical product in the Soviet Union in 1982. That means researchers today work with a compound backed by more than four decades of Russian clinical research, including the landmark 6-year Khavinson-Morozov longevity study in elderly subjects that documented a 4.1-fold reduction in mortality for the Thymalin plus Epithalamin combination group.

Western peptide research rarely matches that timescale or that depth of clinical follow-up. For researchers studying immunosenescence, thymic involution, the peptide bioregulator hypothesis, or the Khavinson longevity protocols that have gained attention in Western gerontology circles, Thymalin is the compound that anchors that entire research tradition.

Pure Peptide Factory stocks research-grade Thymalin with domestic cold-chain shipping and batch-specific HPLC documentation. If you are looking for Thymalin for sale from a supplier that understands what this compound actually is (a polypeptide complex, not a single peptide), this is it.

Why Researchers Choose Pure Peptide Factory for Thymalin

Correct Characterization of a Polypeptide Complex

Most peptide vendors mislabel Thymalin as a “9-amino-acid peptide” or a “32-amino-acid polypeptide hormone.” Neither description is accurate. Thymalin is a heterogeneous polypeptide complex isolated from calf thymus, containing short peptides of 2 to 8 amino acids in the 1,000 to 10,000 Da molecular weight range. The primary active component has been identified as the dipeptide Glu-Trp (also sold separately as Thymogen), though additional dipeptides including Lys-Glu (Vilon) and EDP (Crystagen) contribute to the complex’s overall activity. We characterize our product honestly. Every batch includes analytical documentation confirming the polypeptide complex composition.

Domestic Cold-Chain Shipping for a Peptide Complex

Peptide complexes are more sensitive to handling than single-sequence peptides because temperature excursions can differentially affect components. We ship from domestic cold-storage using phase-change cooling rated for 96-hour protection. Most orders arrive within 1 to 3 business days.

10mg Configuration Matching the Khavinson Protocol

Our 10mg vial configuration matches the standard Khavinson research protocol dosing reported in the published Russian clinical literature (10mg IM daily for 10 days, repeated every 6 months, often combined with 10mg Epitalon). Researchers following published Khavinson protocols can work with a vial size that matches the source material.

Synthesis Logs Archived for 24 Months

Every batch is documented and archived. If your IRB or compliance office requires chain-of-custody records or synthesis documentation, they are available on request.

What Is Thymalin?

The First Peptide Bioregulator

Thymalin was the first compound developed through the Khavinson peptide bioregulation program, a Soviet and subsequently Russian research initiative investigating whether short tissue-specific peptides could restore function to aging organs by modulating gene expression. The program was founded at the Military Medical Academy in Saint Petersburg and continues today at the St. Petersburg Institute of Bioregulation and Gerontology.

The peptide bioregulator hypothesis proposes that low-molecular-weight peptides (2 to 10 amino acids) extracted from young animal tissues contain the signaling information necessary to restore function in the corresponding aged organ. Thymalin is the thymus-targeted bioregulator. Epitalon (pineal), Cortagen (adrenal cortex), Pinealon (CNS), and several others complete the Khavinson family. Thymalin is the prototype that established the entire research program.

Molecular Profile:

• Type: Polypeptide complex extracted from calf thymus
• Primary active component: Glu-Trp dipeptide (also sold as Thymogen)
• Secondary components: Lys-Glu (Vilon), EDP (Crystagen), and other 2-8 amino acid peptides
• Molecular weight range: 1,000 to 10,000 Da (heterogeneous)
• Source: Low-molecular-weight peptides from calf thymus tissue
• Synonyms: Thymalin, Thymic polypeptide bioregulator, Khavinson thymic peptide complex
• Developed by: Morozov and Khavinson, 1981

How Thymalin Works: The Bioregulator Mechanism

The Khavinson group proposed that short peptides modulate gene expression by binding directly to DNA sequences and histone proteins in target tissues. This direct peptide-DNA interaction hypothesis remains controversial in Western molecular biology, where standard peptide signaling is understood to operate through cell surface receptors rather than through direct nuclear interactions. However, the clinical outcomes documented in 40+ years of Russian studies are real, even when the proposed mechanism is debated.

What the published research consistently shows:

Thymic function restoration. Thymalin promotes differentiation of hematopoietic stem cells into T-lymphocytes, particularly in aged animals where thymic output has declined. Research indicates normalization of CD4/CD8 ratios and restoration of T-cell subpopulation balance.

Cytokine modulation. Thymalin upregulates IL-2 and IFN-gamma production while modulating IL-6, IL-8, and other inflammatory mediators. This dual effect, enhancing adaptive immunity while tempering chronic inflammation, is central to its geroprotective research applications.

Gene expression effects. In vitro studies from the Khavinson group demonstrate that Thymalin and its component dipeptides alter gene expression patterns in cultured thymic cells and lymphocytes. Specific pathways affected include those governing T-cell differentiation, apoptosis regulation, and cellular aging markers.

Pineal-thymic axis coordination. Research examining Thymalin combined with Epitalon (pineal bioregulator) shows synergistic effects that exceed either peptide alone. This supports the hypothesis that the pineal and thymus gland operate in coordinated neuroendocrine-immune signaling, and that age-related decline in both produces compound effects that benefit from combination intervention.

Thymalin Research Applications

Immunosenescence and Thymic Involution Research

The thymus begins involuting at puberty and progressively loses functional tissue through adulthood. By age 50 to 70, thymic tissue is largely replaced by adipose tissue, and naive T-cell output drops substantially. This age-related thymic decline is considered a central driver of immunosenescence, which correlates with increased infection susceptibility, reduced vaccine response, and elevated cancer incidence in aging populations.

Thymalin research protocols examine whether exogenous thymic peptide administration can restore aspects of thymic function in aged animal models and human subjects. Published Russian studies report improved T-cell counts, restored CD4/CD8 ratios, enhanced natural killer cell activity, and improved immune competence measured through functional assays including delayed-type hypersensitivity and vaccine response.

The Khavinson-Morozov 6-Year Longevity Study

The landmark clinical trial in the Khavinson research program followed elderly subjects receiving annual Thymalin and/or Epithalamin (pineal polypeptide) courses for 6 years. The study was conducted at the St. Petersburg Institute of Bioregulation and Gerontology and published by Khavinson and Morozov in 2003.

Mortality reduction outcomes versus age-matched controls:

The 6-year combined group outcome remains one of the largest mortality reductions documented for any peptide intervention in published literature. For researchers studying geroprotection, integrated pineal-thymic axis biology, or the translational potential of the Khavinson bioregulator framework, this study is the reference point.

The 2021 Aging and Disease COVID-19 Study (PMC8365293)

During the COVID-19 pandemic, the Khavinson group published a clinical study in Aging and Disease (2021, PMC8365293) examining Thymalin as an adjunctive therapy in severe COVID-19. Combined with standard care, Thymalin accelerated clinical recovery, reduced lymphopenia, and normalized inflammatory markers including C-reactive protein and D-dimer. Hospital mortality in elderly subjects was reportedly halved in the Thymalin group.

This study is directly searchable by its PMC identifier because researchers specifically look for it when evaluating Thymalin’s immunoregulatory evidence base. The findings extended the immunosenescence research rationale to acute viral infection in aged populations, where baseline thymic function correlates with outcomes.

HHV-1 and Viral Immunity Research

A 50-subject clinical study examined thymic peptide administration in subjects with HHV-1 reactivation. Over 2 months of treatment, CD4+ and CD8+ T-cell populations normalized, cytokine profiles shifted toward Th1-mediated antiviral response, and no HHV-1 reactivation occurred in the treatment group during the study period. This supports research applications examining Thymalin’s role in latent viral control where T-cell immunity is the primary defense mechanism.

Neuroendocrine-Immune Axis Research

Thymalin research extends beyond pure immunology into the neuroendocrine-immune axis. The compound modulates hypothalamic-pituitary-adrenal signaling through effects on corticotropin-releasing hormone (CRH), adrenocorticotropic hormone (ACTH), and cortisol regulation. Research applications include stress-induced immunosuppression models, cortisol response studies, and protocols examining how peripheral thymic signaling feeds back to central endocrine regulation.

Thymalin vs Thymosin Alpha-1: Understanding the Difference

This comparison matters because researchers regularly confuse these two thymic peptides. They are not the same compound, and they operate through different mechanisms:

Researchers working within the Khavinson bioregulator framework reach for Thymalin. Researchers focused on TLR9-mediated immunology, hepatitis research, or Western clinical trial data reach for Thymosin Alpha-1. Both are legitimate thymic peptide research compounds, but they answer different research questions and should not be treated as substitutes.

H3: Thymalin vs Thymulin

A third frequently confused compound is Thymulin, which is yet again distinct. Thymulin is a single zinc-dependent nonapeptide (approximately 858 Da) secreted by thymic epithelial cells in vivo. It requires zinc binding to achieve biological activity. Thymalin, by contrast, is a polypeptide complex with no documented zinc dependence. Thymulin and Thymalin are different compounds despite the similar names, and Western peptide suppliers sometimes conflate them in product descriptions.

Epitalon and Thymalin Combination: The Pineal-Thymic Stack

The combination of Epitalon (pineal bioregulator) and Thymalin (thymic bioregulator) is the defining protocol of the Khavinson longevity research program. The hypothesis is that coordinated restoration of pineal and thymic function produces synergistic effects on neuroendocrine-immune axis function and overall geroprotection.

Published combination protocol (Khavinson standard):

• 10mg Thymalin IM daily for 10 days
• 10mg Epitalon IM daily for 10 days (can run concurrently or sequentially)
• Repeat the combined course every 6 months
• Continue annually for multi-year protocols

The 6-year longitudinal study showed the annual combined course produced 4.1x mortality reduction compared to age-matched controls, substantially exceeding either compound alone. Researchers running pineal-thymic axis protocols typically source both peptides from the same supplier to control for batch variability. We stock both under identical cold-storage protocols.

For researchers planning combination studies: the “epithalon and thymalin bulk sale” keyword cluster reflects genuine researcher interest in sourcing both compounds together. Contact us for bulk combination pricing if your protocol requires both peptides in matched quantities.

Thymalin Reddit and Protocol Community Discussions

Reddit and peptide protocol forums reference Thymalin in several common contexts. The Ben Greenfield longevity protocol popularized the Khavinson approach to English-speaking audiences, driving recent interest in Thymalin and Epitalon among researchers who would not otherwise have encountered the Russian literature. Community questions typically involve:

• Whether the polypeptide complex can be substituted by the pure Glu-Trp dipeptide (Thymogen) — research literature suggests the complex produces broader effects than the isolated dipeptide, though Thymogen alone retains significant activity.
• Combination timing with Epitalon — published protocols use sequential or concurrent administration. No systematic research has directly compared them.
• The autoimmune contraindication question — because Thymalin enhances T-cell function, theoretical concerns exist about use in autoimmune research models where T-cell upregulation could worsen disease. This is a valid research design consideration.
• Long-term research protocol design — the Khavinson data supports annual courses rather than continuous administration. Continuous exposure research has not been systematically studied.

We do not provide human dosing recommendations. The published Khavinson protocol (10mg IM daily x 10 days, repeated every 6 months) represents the research reference framework, not a human use recommendation.

Thymalin Dosage Research Protocols

Published Khavinson research protocols provide the framework for research protocol design:

We do not provide human dosing recommendations. The dosing references above are synthesized from peer-reviewed Khavinson group publications and are provided for research protocol design context only. Research-grade Thymalin is sold strictly for laboratory use.

How to Reconstitute Thymalin

H3: Step-by-Step Laboratory Protocol

1. Sanitize the vial stopper with 70% isopropyl alcohol
2. Inject bacteriostatic water slowly against the vial wall. Do not aim directly at the lyophilized powder
3. Allow the complex to dissolve without agitation for 3 to 5 minutes. Polypeptide complexes dissolve more slowly than single-sequence peptides
4. Gently swirl until the solution is clear. Do not shake
5. Inspect for clarity and label with date and concentration before use

Concentration reference:

• 10mg vial + 1mL water = 10mg/mL
• 10mg vial + 2mL water = 5mg/mL
• 10mg vial + 5mL water = 2mg/mL
• Scale to your protocol requirements

Storage Requirements

• Lyophilized powder: 24 months at -20°C, protected from light
• Reconstituted solution: 7 to 14 days at 2 to 8°C. Do not freeze reconstituted Thymalin
• Because Thymalin is a polypeptide complex rather than a single peptide, avoid freeze-thaw cycles that can differentially affect components
• Use reconstituted solution promptly for best research reproducibility

Thymalin for Sale: Regulatory Context

H3: Global Registration Status

Thymalin is registered as a pharmaceutical product in Russia, where it has been clinically used under the Khavinson framework since 1982. It is not FDA approved in the United States, and no Western pharmaceutical registration exists. The Russian registration covers adjunctive immune therapy applications, with extensive clinical outcome data published primarily in Russian biomedical journals but increasingly translated to English peer-reviewed publications in recent years.

Research Use in the United States

Research-grade Thymalin is available for laboratory procurement under research-use-only terms without a prescription. This compound is not for human consumption, veterinary use, or diagnostic application. You must agree to research-use-only terms at checkout.

Why Thymalin Remains Research-Relevant in 2026

The convergence of three factors has driven renewed Western research interest in Thymalin: the growing aging biology research field where immunosenescence is a core topic, the Ben Greenfield and longevity community adoption of Khavinson protocols, and the 2021 COVID-19 Aging and Disease publication (PMC8365293) that brought the Khavinson research tradition to acute viral infection contexts. Researchers now routinely include Thymalin alongside Epitalon and other Khavinson bioregulators in aging and immune research protocols.

Product Specifications

Available Configuration

Thymalin is available in 10mg vials. Select your quantity from the product options above.

Quality Verification

• Purity: 98% minimum component purity (HPLC verified)
• Composition: Polypeptide complex characterized across the 1,000 to 10,000 Da range
• Primary component: Glu-Trp dipeptide presence confirmed
• Endotoxin: Less than 0.1 EU/mL
• Sterility: Verified per USP 71
• Form: Lyophilized polypeptide complex
• Storage: -20°C long-term, 2 to 8°C short-term after reconstitution

Current Batch: #PPF-THY-0426 Purity: 98.6% Download: HPLC Certificate | MS Report

FAQ

What is Thymalin used for in research?

Thymalin is used in immunosenescence and thymic involution research, geroprotection studies examining longevity outcomes, neuroendocrine-immune axis protocols, adjunctive infection research (HHV-1, COVID-19 models), T-cell differentiation studies, and combination bioregulator research with Epitalon and other Khavinson peptides.

Where can I buy Thymalin for research?

Pure Peptide Factory stocks research-grade Thymalin in 10mg vials with batch-specific HPLC documentation. Domestic cold-chain shipping delivers most orders within 1 to 3 business days.

What is Thymalin, exactly?

Thymalin is a polypeptide complex extracted from calf thymus, containing short peptides of 2 to 8 amino acids in the 1,000 to 10,000 Da molecular weight range. The primary active component is the dipeptide Glu-Trp. Thymalin is not a single defined peptide, which distinguishes it from Thymosin Alpha-1 and Thymulin. Most vendors mislabel it; we characterize it correctly.

What is the difference between Thymalin and Thymosin Alpha-1?

Thymalin is a polypeptide complex from calf thymus. Thymosin Alpha-1 is a single 28-amino-acid peptide. Thymosin Alpha-1 has FDA IND status and is approved in 35+ countries for hepatitis research applications. Thymalin has Russian pharmaceutical registration with 40+ years of Khavinson clinical research. They operate through different proposed mechanisms and are not substitutes.

What is the difference between Thymalin and Thymulin?

Thymulin is a zinc-dependent nonapeptide of approximately 858 Da that requires zinc binding for activity. Thymalin is a polypeptide complex (1,000 to 10,000 Da) with no zinc dependence. The names are similar but the compounds are distinct.

What is the Khavinson Thymalin and Epitalon protocol?

The published Khavinson research protocol uses 10mg Thymalin IM daily for 10 days combined with 10mg Epitalon IM daily for 10 days, repeated every 6 months. The 6-year longitudinal study showed 4.1x mortality reduction in the combined group versus age-matched controls. This is a research reference framework, not a human use recommendation.

What does the 2021 Thymalin COVID-19 study show?

The 2021 Aging and Disease publication (PMC8365293) from the Khavinson group examined Thymalin as adjunctive therapy in severe COVID-19. Combined with standard care, Thymalin accelerated clinical recovery, reduced lymphopenia, normalized C-reactive protein and D-dimer levels, and reportedly halved hospital mortality in elderly subjects. The findings extended the immunosenescence research rationale to acute viral infection in aged populations.

How does Thymalin work?

The Khavinson bioregulator hypothesis proposes that Thymalin’s short peptide components bind directly to DNA sequences and histone proteins in target tissues, modulating gene expression. Documented effects include normalized T-cell subpopulations, cytokine modulation (enhanced IL-2 and IFN-gamma, tempered IL-6 and IL-8), and improved thymic output in aged animals. The proposed mechanism remains debated in Western molecular biology, though the clinical outcomes are consistently documented.

Is Thymalin FDA approved?

No. Thymalin is registered as a pharmaceutical product in Russia but not FDA approved in the United States. Research-grade Thymalin is legally available for laboratory procurement under research-use-only provisions.

How should Thymalin be stored?

Lyophilized powder stores at -20°C for up to 24 months protected from light. Reconstituted solution stores at 2 to 8°C for 7 to 14 days. Do not freeze reconstituted solution. Polypeptide complexes are more sensitive to temperature cycling than single-sequence peptides, so minimize storage handling.

Order Thymalin for Research

Secure Checkout

• Credit card, cryptocurrency, or wire transfer
• Same-day dispatch for orders placed before 2 PM EST
• Cold-chain packaging with phase-change cooling
• Discreet labeling with full tracking

Institutional Accounts

Net-30 terms and purchase order acceptance available for universities and pharmaceutical companies. Contact us for bulk pricing on 50 vials or more, including combination Thymalin plus Epitalon bulk orders for pineal-thymic axis research protocols.

Add to cart and get research-grade Thymalin delivered with the documentation your immunosenescence or Khavinson protocol research requires.